Corvus Pharmaceuticals Inc. – Underwriting Agreements Watch

from 8-K 35 pages Amended and Restated Open Market Sale Agreementsm

from 8-K 40 pages 7,900,677 Shares of Common Stock Corvus Pharmaceuticals, Inc. Underwriting Agreement

from S-3 33 pages Open Market Sale Agreementsm

from 8-K 3 pages Corvus Pharmaceuticals, Inc. Amendment No. 1 to Open Market Sale Agreementsm

from S-3 33 pages Open Market Sale Agreementsm

from 8-K 33 pages Corvus Pharmaceuticals, Inc., a Delaware Corporation (The “Company”), Proposes, Subject to the Terms and Conditions Stated Herein, to Issue and Sell From Time to Time Through Jefferies LLC, as Sales Agent and/or Principal (The “Agent”), Shares of the Company’s Common Stock, Par Value $0.0001 Per Share (The “Common Shares”), Having an Aggregate Offering Price of Up to $40,000,000 on the Terms Set Forth in This Agreement (This “Agreement”). Section 1. Definitions (A) Certain Definitions. for Purposes of This Agreement, Capitalized Terms Used Herein and Not Otherwise Defined Shall Have the Following Respective Meanings

from 8-K 30 pages 8,571,429 Shares Common Stock Corvus Pharmaceuticals, Inc. Underwriting Agreement

from S-3 33 pages Open Market Sale Agreementsm

from 8-K 30 pages 7,058,824 Shares Common Stock Corvus Pharmaceuticals, Inc. Underwriting Agreement

from 8-K 33 pages Corvus Pharmaceuticals, Inc. $125,000,000 Common Stock Sales Agreement

from S-1/A 26 pages Corvus Pharmaceuticals, Inc. Underwriting Agreement